Codes / ICD10CM / C18.3

C18.3 Malignant neoplasm of hepatic flexure

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of hepatic flexure (ICD-10 Code: C18.3)
  • Also known as hepatic flexure cancer.

Summary

Malignant neoplasm of the hepatic flexure is a cancer that originates in the hepatic flexure, the bend in the colon where it meets the ascending colon and turns toward the liver. This condition involves the abnormal growth of cells that can invade nearby tissues and spread to other parts of the body if not treated. It disrupts normal digestive function and may lead to systemic complications.

Causes

The exact cause is not fully understood, but it involves genetic mutations that lead to uncontrolled cell growth. Contributing factors may include chronic inflammation, dietary habits, and previous history of colorectal polyps.

Risk Factors

  • Age: Individuals over 50 are at higher risk.
  • Family history of colorectal cancer or polyps.
  • Personal history of inflammatory bowel disease.
  • Genetic conditions such as familial adenomatous polyposis or Lynch syndrome.
  • Lifestyle factors including smoking, obesity, and sedentary lifestyle.

Symptoms

  • Changes in bowel habits (e.g., diarrhea, constipation).
  • Blood in the stool or black, tarry stool.
  • Abdominal pain or discomfort, bloating.
  • Unexplained weight loss and fatigue.

Diagnosis

Diagnosis typically involves a combination of colonoscopy, biopsy, imaging studies (such as CT or MRI scans), and blood tests (including CEA test). Colonoscopy allows direct visualization and tissue sampling, while imaging helps assess tumor extent and metastasis.

Treatment Options

Treatment depends on the stage and may include surgery to remove the tumor, chemotherapy, radiation therapy, or targeted therapies. Surgical options range from local excision to more extensive resections, often followed by adjuvant therapy.

Prognosis and Follow-Up

Prognosis varies based on stage at diagnosis, with earlier detection improving outcomes. Follow-up care includes regular monitoring for recurrence, imaging, and blood tests. Long-term survival rates are higher for localized disease.

Complications

Potential complications include bowel obstruction, perforation, metastasis to other organs (e.g., liver, lungs), and treatment-related side effects like infection or gastrointestinal issues.

Lifestyle & Prevention

  • Maintain a balanced diet rich in fiber and low in processed meats.
  • Engage in regular physical activity and maintain a healthy weight.
  • Avoid smoking and limit alcohol consumption.
  • Consider screening colonoscopies as recommended for high-risk individuals.

When to Seek Professional Help

Seek medical attention for persistent changes in bowel habits, unexplained weight loss, blood in stool, or severe abdominal pain. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use C18.3 for malignant neoplasms specifically located in the hepatic flexure. Ensure documentation specifies the anatomical site and confirms malignancy. Differentiate from other colon segments (e.g., ascending, transverse) to avoid miscoding. Verify histological type and staging details if available for comprehensive coding.

Book a walkthrough

C18.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.